<DOC>
	<DOC>NCT02712619</DOC>
	<brief_summary>Two doses of metformin with 12 hour interval - low dose group (375/250 mg) - high dose group (1000/1000mg)</brief_summary>
	<brief_title>Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers</brief_title>
	<detailed_description>A study to evaluate and compare the pharmacokinetic-pharmacodynamic relationship between different metformin dose groups.</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 20 to 45 Body weight 50 to 100 kg fasting serum glucose 70 to 125 mg/dL who provide informed consent voluntarily any significant renal, gastrointestinal, hepatic, and metabolic condition any co/prior medication within 14 days of study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>